Uncomplicated Falciparum Malaria: Clinical Trials

9 trials for Uncomplicated Falciparum Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 withdrawn, 1 active not recruiting, 1 unknown. 6 Phase 2, 4 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Withdrawn 2, Active not recruiting 1
Phase 34Withdrawn 2, Active not recruiting 1, Completed 1
Phase 42Completed 1, Unknown 1

Follow Uncomplicated Falciparum Malaria: new trials by email Literature Review of Uncomplicated Falciparum Malaria trials Research Report on Uncomplicated Falciparum Malaria

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
Artemether-lumefantrine, Dihydroartemisinin-piperaquine - Uncomplicated Falciparum Malaria
Phase 2 / Phase 3Active not recruitingJohns Hopkins Bloomberg School of Public Health1822019-06-192025-12-17
Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania
Artesunate amodiaquine - Uncomplicated Falciparum Malaria
Phase 4CompletedNational Institute for Medical Research, Tanzania3332017-07-142018-02-13
Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar
Arterolane maleate-piperaquine phosphate (Synriam), Dihydroartemisinin-piperaquine phosphate (Duocotexin) - Uncomplicated Falciparum Malaria, Artemisinin-resistant
Phase 2 / Phase 3WithdrawnUniversity of Oxford2015-06-012015-11-03
Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children
artesunate (AS) - amodiaquine (AQ) - methylene blue (MB) - Uncomplicated Falciparum Malaria
Phase 2CompletedHeidelberg University1802011-08-012012-12-05
Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia
Artemisone/Mefloquine (AmiM3), Artesunate - Uncomplicated Falciparum Malaria
Phase 2 / Phase 3WithdrawnUniversity of Oxford2010-10-012018-08-31
Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria
AM(FDC), AM(LT), AL - Uncomplicated Falciparum Malaria
Phase 4UnknownMedecins Sans Frontieres, Netherlands6002008-12-012009-05-15
A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
Dihydroartemisinin + Piperaquine (Artekin), artesunate-sulphadoxin/pyrimethamine, chloroquine - Uncomplicated Falciparum Malaria, Vivax Malaria
Phase 3CompletedUniversity of Oxford10862007-07-012018-05-09
Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh
azithromycin plus artesunate, Artesunate - Uncomplicated Falciparum Malaria
Phase 2CompletedMedical University of Vienna2282006-08-012012-11-01
Trial of Artesunate Combination Therapy in Pakistan
artesunate (AS), sulphadoxine-pyrimethamine (SP), Chloroquine (CQ) - Uncomplicated Falciparum Malaria
Phase 2CompletedLondon School of Hygiene and Tropical Medicine5882001-07-012009-08-14

Narrower conditions

Malaria, Falciparum (3)  ·  Malaria, Vivax (1)

Broader conditions

Infections (3)  ·  Malaria (3)  ·  Mosquito-Borne Diseases (3)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Vector Borne Diseases (3)

Interventions

Artesunate (4)  ·  Artemether, Lumefantrine Drug Combination (2)  ·  Chloroquine (2)  ·  Mefloquine (2)  ·  Amodiaquine (1)  ·  Azithromycin (1)  ·  Methylene Blue (1)  ·  Primaquine (1)  ·  Pyrimethamine (1)  ·  amodiaquine, artesunate drug combination (1)  ·  artemisone (1)  ·  artenimol (1)  ·  fanasil, pyrimethamine drug combination (1)  ·  piperaquine (1)

Sponsors

University of Oxford (3)  ·  Heidelberg University (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Medecins Sans Frontieres, Netherlands (1)  ·  Medical University of Vienna (1)  ·  National Institute for Medical Research, Tanzania (1)

Countries

Afghanistan (1)  ·  Bangladesh (1)  ·  Burkina Faso (1)  ·  Burma (1)  ·  Cambodia (1)  ·  Pakistan (1)  ·  Tanzania (1)  ·  Zambia (1)

Top investigators

Arjen M Dondorp, MD (1)  ·  Deus S Ishengoma, PhD (1)  ·  Duong Socheat, MD (1)  ·  Frank Smithuis, MD (1)  ·  Ghulam R Awab, MD (1)  ·  Harald Noedl, MD, MCTM,PhD (1)  ·  Mark W Rowland, PhD (1)  ·  Rashidul Haque, MBBS,PhD (1)  ·  William J Moss, MD MPH (1)

Results publications

PMID 20409302, PMID 20557237, PMID 20832366, PMID 22303437, PMID 25267980, PMID 26917051, PMID 30909922